CASP1 and amyotrophic lateral sclerosis: The pyroptotic pathway provides various targets for potential interventional approaches in the future (e.g., NLRP3, inflammasome activation, caspase-1, GSDM family), however, as of now the effect of their modulation has remained mostly unexplored in ALS (Fig. 2).